Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Vesna, Bišof"'
Publikováno v:
Acta Clinica Croatica, Vol 61., Iss 1., Pp 52-61 (2022)
The aim of the study was to investigate the correlation between chemotherapy- induced peripheral neuropathy (CIPN) and quality of life, as well as to establish whether there was a difference in peripheral neuropathy symptoms and their effect on the
Externí odkaz:
https://doaj.org/article/ecf0120d8d9844b393d7bdb73edc1c48
Autor:
Drago Prgomet, Vesna Bišof, Ratko Prstačić, Renata Curić Radivojević, Lovorka Brajković, Ivana Šimić
Publikováno v:
Acta Clinica Croatica, Vol 61., Iss Supplement 4, Pp 77-87 (2022)
Head and neck cancers are associated with significant morbidity and mortality despite advancements in treatment in recent decades. A multidisciplinary approach to the treatment of these diseases is thus of essential importance and is becoming the g
Externí odkaz:
https://doaj.org/article/9b1675d8591743be8ccfd7caa2108187
Autor:
Vanja Vučićević Boras, Maja Milenović, Vesna Bišof, Aleksandra Fučić, Marco Bruzzone, Marcello Ceppi, Sandra Baranović, Zoran Rakušić, Igor Blivajs
Publikováno v:
Central European Journal of Public Health. 27:106-109
Objectives: The high incidence of head and neck cancer (HNC), significantly associated with living environment and behaviour, can be prevented more efficiently. The aim of this study was to evaluate the environmental and behavioural risk factors for
Autor:
Josipa Flam, Mario Boban, Vesna Bišof, Marko Zelić, Zdravko Perko, Eduard Vrdoljak, Nadan Rustemović, Jasna Radić, Meliha Solak Mekić, Antonio Juretić, Davor Štimac, Željko Krznarić, Ante Bolanča, Tomislav Omrčen, Ingrid Belac Lovasić, Ivica Sjekavica, Stjepko Pleština, Slavko Gašparov
Publikováno v:
Liječnički vjesnik. 140:285-292
Although the incidence of the most frequent malignant gastric tumour, adenocarcinoma, has been decreasing, during the last decades the incidence of proximal localizations of gastric cancer as well as esophagogastric cancer has been increasing. Due to
Autor:
Zvonimir Curić, Tomislav Sorić, Igor Tomašković, Tihana Boraska Jelavić, Kristijan Krpina, Željko Kaštelan, Tomislav Kuliš, Dražen Huić, Vesna Bišof, Ana Marija Alduk, Dag Zahirović, Marija Gamulin, Mladen Solarić, Stela Bulimbašić, Katarina Vilović, Tomislav Omrčen, Ante Punda, Blanka Jakšić, Ana Fröbe
Publikováno v:
Liječnički vjesnik. 141
Autor:
Vanja Vučićević Boras, Cedna Tomasovic-Loncaric, Danko Velimir Vrdoljak, Aleksandra Fučić, Nicolas Le Novère, Dragana Gabrić, Igor Blivajs, Mihajlo Virag, Vesna Bišof, Zoran Rakušić
Publikováno v:
Tumori Journal. 104:9-14
The worldwide annual incidence of oral squamous cell carcinoma (OSCC) is over 300,000 cases with a mortality rate of 48%. This cancer type accounts for 90% of all oral cancers, with the highest incidence in men over 50 years of age. A significantly i
Autor:
Vesna, Bišof
Publikováno v:
Acta clinica Croatica
Volume 58.
Issue Supplement 2
Acta Clinica Croatica
Volume 58.
Issue Supplement 2
Acta Clinica Croatica
The standard of treatment of metastatic hormone-sensitive prostate cancer (mHSPC) is androgen deprivation therapy (ADT ) with docetaxel or abiraterone. However, numerous retrospective studies suggested outcome benefit of prostate radiotherapy. Small
Publikováno v:
Acta clinica Croatica. 61(1)
The aim of the study was to investigate the correlation between chemotherapy-induced peripheral neuropathy (CIPN) and quality of life, as well as to establish whether there was a difference in peripheral neuropathy symptoms and their effect on the qu
Aim To compare intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland-sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma with regard to outcomes and dose d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed1073062e63085731b29d6895915e6d
https://www.bib.irb.hr/960431
https://www.bib.irb.hr/960431
Publikováno v:
International Journal of Person Centered Medicine. 4:19-22
In the last decade there has been a strong development and new discoveries in the field of oncology. Molecular biology has undergone the greatest evolution and this makes difficult for clinicians to follow closely. In fact, among thousands of new dis